Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 107 companies set new 52-week lows.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Mustang Bio (NASDAQ:MBIO) shares rose 6.9% to $1.39 during Friday's after-market session. The company's market cap stands at $129.8 million.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength.
Adaptimmune To Present Data Updates At Upcoming CTOS And SITC Meetings
Adaptimmune Therapeutics plc (NASDAQ:ADAP), a leader in cell therapy to treat cancer, will present clinical and translational data from the Phase 2 SPEARHEAD-1 trial at the Connective Tissue Oncology Society (CTOS)
Wells Fargo Maintains Equal-Weight on Adaptimmune Therapeutics, Raises Price Target to $7
Wells Fargo maintains Adaptimmune Therapeutics (NASDAQ:ADAP) with a Equal-Weight and raises the price target from $6 to $7.
Looking Into Adaptimmune Therapeutics’s Return On Capital Employed
Adaptimmune Therapeutics (NASDAQ:ADAP) brought in sales totaling $3.10 million during Q2 according to data provided by Benzinga Pro.However, earnings decreased 4.22%, resulting in a loss of $39.05 million.
Adaptimmune Shares Encouraging Data From Solid Tumor Trial
Adaptimmune Therapeutics plc (NASDAQ:ADAP) has announced updated data from its Phase 1 SURPASS trial in multiple solid tumors evaluating ADP-A2M4CD8. ADP-A2M4CD8…